Literature DB >> 11997159

Intranasal immunization with lipoteichoic acid and cholera toxin evokes specific pharyngeal IgA and systemic IgG responses and inhibits streptococcal adherence to pharyngeal epithelial cells in mice.

Yuji Yokoyama1, Yasuaki Harabuchi.   

Abstract

OBJECTIVE: Streptococcus (S.) pyogenes is common cause of acute tonsillitis. Lipoteichoic acid (LTA), which is a common constitute of the cell surface of most gram positive bacteria, is known to act as a substance of bacterial site for adherence to epithelium and antiserum to LTA is reported to inhibit bacterial attachment to epithelial cells in vitro. Cholera toxin subunit B (CT-B) is known to be a mucosal adjuvant. The purpose of this study is to investigate whether intranasal immunization with LTA and CT-B may be a possible candidate for vaccine formulation.
METHODS: Six-week-old male BALB/c mice were assigned to three experimental groups, mice immunized with LTA and CT-B, with LTA alone and with phosphate buffered saline (PBS) as a control. Immunizations were performed intranasally every 2 days for 2 weeks in every group. At the 21 days after immunization, sera, pharyngeal washings and pharyngeal epithelial cells were taken. The levels of serum IgG and pharyngeal IgA antibodies to LTA were measured by enzyme-linked immunosorbent assay (ELISA). The adherence rates of S. pyogenes pretreated by pharyngeal washings to pharyngeal epithelial cells from the mice were determined by in vitro adherence assay.
RESULTS: The serum anti-LTA IgG antibody levels of either mice immunized with LTA and CT-B or mice immunized with LTA alone were significantly higher than those of mice administered with PBS alone. The pharyngeal anti-LTA IgA antibody levels of the mice immunized with LTA and CT-B were significantly higher than those of either mice with LTA alone or mice with PBS alone. The streptococcal adherence rates to pharyngeal epithelial cells were significantly decreased by pretreatment with pharyngeal washings from the mice immunized with LTA and CT-B as compared with pretreatment with those from either mice with PBS or mice with LTA alone.
CONCLUSIONS: These data shows that intranasal immunization with LTA and CT-B evokes a good pharyngeal IgA response as well as systemic IgG response to LTA and inhibits streptococcal adherence to pharyngeal epithelial cells, suggesting that intranasal immunization with LTA and CT-B may be an effective approach to prevent streptococcal tonsillitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997159     DOI: 10.1016/s0165-5876(02)00021-6

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  10 in total

Review 1.  Mechanisms of Cholera Toxin in the Modulation of TH17 Responses.

Authors:  Hsing-Chuan Tsai; Reen Wu
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

2.  Pharyngeal Immunity in Early Vertebrates Provides Functional and Evolutionary Insight into Mucosal Homeostasis.

Authors:  Wei-Guang Kong; Yong-Yao Yu; Shuai Dong; Zhen-Yu Huang; Li-Guo Ding; Jia-Feng Cao; Fen Dong; Xiao-Ting Zhang; Xia Liu; Hao-Yue Xu; Kai-Feng Meng; Jian-Guo Su; Zhen Xu
Journal:  J Immunol       Date:  2019-10-23       Impact factor: 5.422

Review 3.  Cutting edge issues in rheumatic fever.

Authors:  Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

4.  Defense from the Group A Streptococcus by active and passive vaccination with the streptococcal hemoprotein receptor.

Authors:  Ya-Shu Huang; Morly Fisher; Ziyad Nasrawi; Zehava Eichenbaum
Journal:  J Infect Dis       Date:  2011-06-01       Impact factor: 5.226

5.  Cholera toxin directly enhances IL-17A production from human CD4+ T cells.

Authors:  Hsing-Chuan Tsai; Reen Wu
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

6.  Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1.

Authors:  Agnieszka Rynda; Massimo Maddaloni; Dagmara Mierzejewska; Javier Ochoa-Repáraz; Tomasz Maslanka; Kathryn Crist; Carol Riccardi; Beata Barszczewska; Kohtaro Fujihashi; Jerry R McGhee; David W Pascual
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

7.  Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.

Authors:  Quanyi Chen; Jay Dintaman; Andrew Lees; Goutam Sen; David Schwartz; Mark E Shirtliff; Saeyoung Park; Jean C Lee; James J Mond; Clifford M Snapper
Journal:  Infect Immun       Date:  2013-05-06       Impact factor: 3.441

8.  Synthetic teichoic acid conjugate vaccine against nosocomial Gram-positive bacteria.

Authors:  Diana Laverde; Dominique Wobser; Felipe Romero-Saavedra; Wouter Hogendorf; Gijsbert van der Marel; Martin Berthold; Andrea Kropec; Jeroen Codee; Johannes Huebner
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

9.  IL-28 supplants requirement for T(reg) cells in protein sigma1-mediated protection against murine experimental autoimmune encephalomyelitis (EAE).

Authors:  Agnieszka Rynda; Massimo Maddaloni; Javier Ochoa-Repáraz; Gayle Callis; David W Pascual
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

Review 10.  Immunoglobulins, Mucosal Immunity and Vaccination in Teleost Fish.

Authors:  Yongyao Yu; Qingchao Wang; Zhenyu Huang; Liguo Ding; Zhen Xu
Journal:  Front Immunol       Date:  2020-10-02       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.